144Filing Date: Sep 2, 2026
Resmed (RMD)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001628280-26-060229
Sale Plan
Peter C Farrell
Director·Resmed
Proposed
CommonNYSE
Shares970
Est. DateSep 2
Market Value$227.6K
BrokerMerrill Lynch
AcquisitionStock Option · Peter C Farrell
Acquired DateNov 11, 2015
Amount Acquired970
10b5-1 Plan Adoption08/12/2025
% Outstanding0.0007%
10b5-1
Exercise / Payment Details
Paid: Nov 11, 2015Method: Cash
Sales Past 3 Months Total $1.80M · 8.00K sh. expand_more
Aug
5
$1.80M
8.00K sh.
Signature & Compliance expand_more
Notice DateSep 2, 2026
10b5-1 Plan Adoption08/12/2025
Signature PETER C FARRELL
Issuer Info expand_more
CompanyResMed INC
CIK0000943819
Phone858-746-2400
Address9001 Spectrum Center Blvd, SAN DIEGO, CA 92123